NasdaqGM:ATAIPharmaceuticals
A Look At AtaiBeckley (ATAI) Valuation After Q1 Earnings Beat And Pipeline Progress
AtaiBeckley (ATAI) shares were in focus after first quarter results showed a net loss of US$29.78 million and an earnings per share loss of US$0.08, with management highlighting cash resources and progress across key mental health programs.
See our latest analysis for AtaiBeckley.
The latest Q1 update, including the earnings beat and progress toward Phase 3 trials, comes against a backdrop of a 11.63% year to date share price return and a 109.71% 1 year total shareholder return. This suggests...